approved EB-2 (NIW)

Research Associate

Medicinal Chemistry · China · 2025-03-07

Processing Time
52 days
Decision Date
2025-03-07
Location
Utah
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design and develop novel antimicrobial compounds for in vitro and in vivo applications to combat resistant pathogens and bridge the gap between basic discovery and clinical translation.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent challenges in global health by creating therapeutic options for resistant pathogens.

2 Well Positioned to Advance the Endeavor Met

The petitioner's Ph.D., extensive publication record, and history of major funding demonstrate he is uniquely positioned to succeed.

3 Balance of Factors Met

It was determined to be in the interest of the U.S. to waive the job offer requirement to benefit public health and alleviate societal burdens.

Why This Petition Was Approved

The petition was approved based on 25 peer-reviewed journal articles with 252 citations and over 110 completed peer reviews. Evidence included research funding from the NIH, CDMRP, and NSFC, as well as expert recommendation letters satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.

Research Assistant

Biotechnology · Egypt

WeGreened EB-2 (NIW) rfe approved
Massachusetts 395 days 2025-07-17
The petitioner proposes to continue research in microbiology focused on discovering antimicrobial agents and elucidating their mechanisms to combat multidrug-resistant bacteria. The work involves developing phage therapies, nanoparticle-drug hybrids, and innovative antimicrobial delivery systems to replace or augment conventional antibiotics. This endeavor aims to address the global healthcare emergency of antibiotic resistance and improve drug treatment efficacy.

Research Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
2 days 2023-06-07
The petitioner proposes to research and develop new chemical synthesis methods for novel therapeutic agents and implement medicinal chemical strategies for developing novel antimicrobial therapeutic agent-discovery programs. This work specifically targets pressing issues such as antimicrobial resistance, antibiotic discovery, and the treatment of Alzheimer’s disease.

Research Assistant

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Pennsylvania 109 days 2022-05-02
The petitioner proposes to continue her research in biomedical science, specifically focusing on advancing the understanding of mechanisms behind deadly diseases such as cholera, Salmonella, and COVID-19. Her work involves characterizing complex factors in antibiotic production and resistance to accelerate the development of novel, therapeutically effective antibiotics. The research aims to mitigate the threat of bacterial infections and minimize the prevalence and mortality of infectious diseases in the United States.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 52 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist